Abstract
Heterotrimeric guanine nucleotide-binding (G) protein-coupled receptor kinases (GRKs) are cytosolic proteins that are known to contribute to the adaptation of the heptahelical G protein-coupled receptors (GPCRs) and to regulate downstream signals through these receptors. GPCRs mediate the action of messengers that are key modulators of cardiac and vascular cell function, such as growth and differentiation. GRKs are members of a multigene family, which are classified into three subfamilies and are found in cardiac, vascular and cerebral tissues. Increasing evidence strongly supports the hypothesis that vascular damage is an early contributor to the development of Alzheimer disease (AD) and/or other pathology that can mimic human AD. Based on this hypothesis, and since kinases of this family are known to regulate numerous receptor functions both in the brain, myocardium and elsewhere, we explored cellular and subcellular localization by immunoreactivity of G protein-coupled receptor kinase 2 (GRK2), also known as ?-adrenergic receptor kinase-1(?ARK1), in the early pathogenesis of AD and in ischemia reperfusion injury models of brain hypoperfusion. In the present study, we used the two-vessel carotid artery occlusion model, namely the 2-VO system that results in chronic brain hypoperfusion (CBH) and mimics mild cognitive impairment (MCI) and vascular changes in AD pathology. Our findings demonstrate the early overexpression of GRK2 member kinase in the cerebrovasculature, especially endothelial cells (EC) following CBH, as well as in select cells from human AD tissue. We found a significant increase in GRK2 immunoreactivity in the EC of AD patients and after CBH, which preceded any amyloid deposition. Since GRK2 activity is associated with certain compensatory changes in brain cellular compartments and in ischemic cardiac tissue, our findings suggest that chronic hypoperfusion initiates oxidative stress in these conditions and appears to be the main initiating injury stimulus for disruption of brain and cerebrovascular homeostasis and metabolism.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aliev G, D Seyidova, ML Neal, J Shi, BT Lamb, SL Siedlak, HV Vinters, E Head, G Perry, JC LaManna, RP Friedland and CV Cotman (2002a) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.Ann. NYAcad. Sci. 977, 45–64.
Aliev G, MA Smith, D Seyidova, ML Neal, BT Lamb, A Nunomura, EK Gasimov, HV Vinters, G Perry, JC LaManna and RP Friedland (2002b) The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer’s disease.Brain Pathol. 12, 21–35.
Aliev G, MA Smith, ME Obrenovich, JC de la Torre and G Perry (2003) Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.Neurotoxicity Res. 5, 491–504.
Aliev G, MA Smith, JC de la Torre and G Perry (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer’s disease.Mitochondrion 4, 649–663.
Arai K, Y Maruyama, M Nishida, S Tanabe, S Takagahara, T Kozasa, Y Mori, T Nagao and H Kurose (2003) Differential requirement of G alpha12, G alpha13, G alphaq and G beta gamma for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation.Mol. Pharmacol. 63, 478–488.
Arriza JL, TM Dawson, RB Simerly, LJ Martin, MG Caron, SH Snyder and RJ Lefkowitz (1992) The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain.J. Neurosci. 12, 4045–4055.
Boucher M, S Nim, C de Montigny and G Rousseau (2004) Alterations of beta-adrenoceptor responsiveness in postischemic myocardium after 72 h of reperfusion.Eur. J. Pharmacol. 495, 185–191.
Carman CV, MP Lisanti and JL Benovic (1999) Regulation of G protein-coupled receptor kinases by caveolin.J. Biol. Chem. 274, 8858–8864.
Choi DJ, WJ Koch, JJ Hunter and HA Rockman (1997) Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase.J. Biol. Chem. 272, 17223–17229.
de la Torre JC and G Aliev (2005) Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.J. Cereb. Blood Flow Metab. 25, 663–672.
de la Torre JC and T Fortin (1991) Partial or global rat brain ischemia. The SCOT model.Brain Res. Bull. 26, 365–372.
de la Torre JC, J Saunders, T Fortin, K Butler and M Richard (1991) Return of ATP/PCr and EEG after 75 minutes of global brain ischemia.Brain Res. 542, 71–76.
de la Torre JC, T Fortin, GA Park, KS Butler, P Kozlowski, BA Pappas, H de Socarraz, JK Saunders and MT Richard (1992a) Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats.Brain Res. 582, 186–195.
de la Torre JC, T Fortin, GA Park, JK Saunders, P Kozlowski, K Butler, H de Socarraz, BA Pappas and M Richard (1992b) Aged but not young rats develop metabolic, memory deficits after chronic brain ischaemia.Neurol. Res. 14, 177–180.
de la Torre JC, K Butler, P Kozlowski, T Fortin and JK Saunders (1995) Correlates between nuclear magnetic resonance spectroscopy, diffusion weighted imaging, and CA1 morphometry following chronic brain ischemia.J. Neurosci. Res. 41, 238–245.
Elorza A, P Penela, S Sarnago and F Mayor Jr (2003) MAPKdependent degradation of G protein-coupled receptor kinase 2.J. Biol. Chem. 278, 29164–29173.
Erdtmann-Vourliotis M, P Mayer, S Ammon, U Riechertand and V Hollt (2001) Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain.Mol. Brain Res. 95, 129–137.
Feldman RD (2002) Deactivation of vasodilator responses by GRK2 overexpression: a mechanism or the mechanism forhypertension?Mol. Pharmacol. 61, 707–709.
Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.Pharmacol. Rev. 53, 1–24.
Fredericks ZL, JA Pitcher and RJ Lefkowitz (1996) Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor.J. Biol. Chem. 271, 13796–13803.
Freedman NJ, AS Ament, M Oppermann, RH Stoffel, ST Exum and RJ Lefkowitz (1997) Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G proteincoupled receptor kinase specificity.J. Biol. Chem. 272, 17734–17734.
Ge J and NM Barnes (1996) Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.Eur. J. Pharmacol. 22, 299–306.
Haga K, H Ogawa, T Haga and H Murofushi (1998) GTP-bindingprotein- coupled receptor kinase 2 (GRK2) binds and phosphorylates tubulin.Eur. J. Biochem. 255, 363–368.
Hagen SA, AL Kondyra, HP Grocott, H El-Moalem, D Bainbridge, JP Mathew, MF Newman, JG Reves, DA Schwinn and MM Kwatra (2003) Cardiopulmonary bypass decreases G proteincoupled receptor kinase activity and expression in human peripheral blood mononuclear cells.Anesthesiology 98, 343–348.
Harris CA, TT Chuang and CA Scorer (2001) Expression of GRK2 is increased in the left ventricles of cardiomyopathic hamsters.Basic Res. Cardiol. 96, 364–368.
Hata JA and WJ Koch (2003) Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.Mol. Interv. 3, 264–272.
Hirai K, G Aliev, A Nunomura, H Fujioka, RL Russell, CS Atwood, AB Johnson, Y Kress, HV Vinters, M Tabaton, S Shimohama, AD Cash, SL Siedlak, PL Harris, PK Jones, RB Petersen, G Perry and MA Smith (2001) Mitochondrial abnormalities in Alzheimer’s disease.J. Neurosci. 21, 3017–3023.
Hu JH, H Zhang, R Wagey, C Krieger and SL Pelech (2003) Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord.J. Neurochem. 85, 432–442.
Iaccarino G and WJ Koch (2003) Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets.Assay Drug Dev. Technol. 1, 347–355.
Iaccarino G, E Barbato, E Cipolletta, V De Amicis, KB Margulies, D Leosco, B Trimarco and WJ Koch (2005) Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure.Eur. Heart J. 26, 1752–1758.
Iacovelli L, R Franchetti, D Grisolia and A De Blasi (1999) Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and A(1) adenosine receptormediated responses.Mol. Pharmacol. 56, 316–324.
Kwon S, LH Fang, B Kim, TS Ha, SJ Lee and HY Ahn (2004) p38 Mitogen-activated protein kinase regulates vasoconstriction in spontaneously hypertensive rats.J. Pharmacol. Sci. 95, 267–272.
Lea P, MT Faden and IA Faden (2003) Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders.Drug News Perspect. 16, 513–522.
Liu S, RT Premont, CD Kontos, S Zhu and DC Rockey (2003) Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt.J. Biol. Chem. 278, 49929–49935.
Liu S, RT Premont, CD Kontos, S Zhu and DC Rockey (2005) A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension.Nat. Med. 11, 952–958.
Lodowski DT, JA Pitcher, WD Capel, RJ Lefkowitz and JJ Tesmer (2003) Keeping G proteins at bay: a complex between G pro tein-coupled receptor kinase 2 and G betagamma.Science 300, 1256–1262.
Mayor F Jr, P Penela and A Ruiz-Gomez (1998) Role of G proteincoupled receptor kinase 2 and arrestins in beta-adrenergic receptor internalization.Trends Cardiovasc. Med. 8, 234–240.
Nunomura A, G Perry, G Aliev, K Hirai, A Takeda, EK Balraj, PK Jones, H Ghanbari, T Wataya, S Shimohama, S Chiba, CS Atwood, RB Petersen and MA Smith (2001) Oxidative damage is the earliest event in Alzheimer disease.J. Neuropathol. Exp. Neurol. 60, 759–767.
Obrenovich ME, AK Raina, O Ogawa, CS Atwood, L Morelli and MA Smith (2005)Cell-cycle Mechanisms in Neuronal Death: a New Beginning or a Final exit? (Nicoletti, Ferdinando, Agata Copani, Eds.) (Landes Bioscience) 8, 1-15.
Pappas BA, JC de la Torre, CM Davidson, MT Keyes and T Fortin (1996) Chronic reduction of cerebral blood flow in the adult rat: late-emerging CA1 cell loss and memory dysfunction.Brain Res. 708, 50–58.
Paris D, J Humphrey, A Quadros, N Patel, R Crescentini, F Crawford and M Mullan (2003) Vasoactive effects of Abeta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer’s disease: role of inflammation.Neurol. Res. 25, 642–651.
Penela P, M Alvarez-Dolado, A Munoz and F Mayor Jr (2000) Expression patterns of the regulatory proteins G protein-coupled receptor kinase 2 and beta-arrestin 1 during rat postnatal brain development: effect of hypothyroidism.Eur. J. Biochem. 267, 4390–4396.
Pitcher JA, RA Hall, Y Daaka, J Zhang, SS Ferguson, S Hester, S Miller, MG Caron, RJ Lefkowitz and LS Barak (1998) The G protein-coupled receptor kinase 2 is a microtubule-associated protein kinase that phosphorylates tubulin.J. Biol. Chem. 273, 12316–12324.
Pitcher JA, JJ Tesmer, JL Freeman, WD Capel, WC Stone and RJ Lefkowitz (1999) Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases.J. Biol. Chem. 274, 34531–34534.
Raina AK, A Hochman, X Zhu, CA Rottkamp, A Nunomura, SL Siedlak, H Boux, RJ Castellani, G Perry and MA Smith (2001) Abortive apoptosis in Alzheimer’s disease.Acta Neuropathol. (Berl.) 101, 305–310.
Ramos-Ruiz R, P Penela, RB Penn and F Mayor Jr (2000) Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells.Circulation 101, 2083–2089.
Robinson SR and GM Bishop (2002) Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease.Neurobiol. Aging 23, 1051–1072.
Roder HM, PA Eden and VM Ingram (1993) Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer’s disease.Biochem. Biophys. Res. Commun. 193, 639–647.
Sakai S, T Miyauchi, M Kobayashi, I Yamaguchi, K Goto and Y Sugishita (1996) Inhibition of myocardial endothelin pathway improves long-term survival in heart failure.Nature 384, 353–355.
Sallese M, L Salvatore, E D’Urbano, G Sala, M Storto, T Launey, F Nicoletti, T Knopfel and A De Blasi (2000) The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1.FASEB J. 14, 2569–2580.
Sarnago S, A Elorza and F Mayor Jr (1999) Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase.J. Biol. Chem. 274, 34411–34416.
Suo Z, M Wu, BA Citron, GT Wong and BW Festoff(2004) Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer’s disease: an association with early beta-amyloid accumulation.J. Neurosci. 24, 3444–3452.
Thebaud B, F Ladha, ED Michelakis, M Sawicka, G Thurston, F Eaton, K Hashimoto, G Harry, A Haromy, G Korbutt and SL Archer (2005) Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.Circulation 112, 2477–2486.
Theilade J, C Strom, T Christiansen, S Haunso and SP Sheikh (2003) Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat.Basic Res. Cardiol. 98, 97–103.
Tsuchiya M, K Sako, S Yura and Y Yonemasu (1992) Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats.Exp. Brain Res. 89, 87–92.
Ungerer M, K Kessebohm, K Kronsbein, MJ Lohse and G Richardt (1996) Activation of beta-adrenergic receptor kinase during myocardial ischemia.Circ. Res. 79, 455–460.
Willets JM, RA Challiss and SR Nahorski (2003) Non-visual GRKs: are we seeing the whole picture?Trends Pharmacol. Sci. 24, 626–633.
Yoshida N, K Haga and T Haga (2003) Identification of sites of phosphorylation by G-protein-coupled receptor kinase 2 in betatubulin.Eur. J. Biochem. 270, 1154–1163.
Zhu X, HG Lee, AK Raina, G Perry and MA Smith (2002) The role of mitogen-activated protein kinase pathways in Alzheimer’s disease.Neurosignals 11, 270–281.
Zhu X, MA Smith, G Perry and G Aliev (2004) Mitochondrial failures in Alzheimer’s disease.Am. J. Alzheimer’s Dis. Demen. 19, 345–352.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Obrenovich, M.E., Smith, M.A., Siedlak, S.L. et al. Overexpression of GRK2 in alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. neurotox res 10, 43–56 (2006). https://doi.org/10.1007/BF03033333
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033333